IBBQ

Invesco Nasdaq Biotechnology ETF · NAS

Category Health Care
Expense Ratio 0.19%
Listing Date Jun 11, 2021
Volume 10,463.0
Market Cap (AUM) $38.23M

Performance

-3.53%

-1.73%

-12.08%

-2.26%

-0.54%

YTD

+5.38%

Top Holdings

Name
Symbol
%Assets
Amgen Inc.AMGN9.17%
Vertex Pharmaceuticals IncorporatedVRTX9.08%
Regeneron Pharmaceuticals, Inc.REGN8.77%
Gilead Sciences, Inc.GILD7.70%
Moderna, Inc.MRNA5.31%
Astrazeneca PLC Sponsored ADRAZN4.73%
Biogen Inc.BIIB3.40%
Alnylam Pharmaceuticals, IncALNY2.05%
Illumina, Inc.ILMN1.78%
BioMarin Pharmaceutical Inc.BMRN1.65%

Advanced Technical Analysis

Technical Analysis of IBBQ 2024-12-20

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 10 indicating strong downward momentum, while the Oscillators Score of 46 suggests a neutral stance, and the Technical Score of 28 reinforces the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to ...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Recent News & Updates

2022-01-19 08:38
Apexium Financial, LP Buys Fidelity MSCI Health Care Index ETF, Fidelity MSCI Information ...(Yahoo Finance)
2021-06-16 18:00
By next summer we'll have enough vaccines to vaccinate the world: Eli Lilly CEO(Yahoo Finance)
2021-06-16 18:00
Influencers with Andy Serwer: David Ricks(Yahoo Finance)
2021-06-15 21:57
FDA shifting the bar for approval with new Alzheimers drug: Eli Lilly CEO(Yahoo Finance)
2021-06-10 21:00
Invesco Expands Longstanding Partnership with Nasdaq with Two New Thematic Technology ETFs(Yahoo Finance)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.